会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • Antisense antiviral compound and method for treating influenza viral infection
    • 反义抗病毒化合物及治疗流感病毒感染的方法
    • US20060148747A1
    • 2006-07-06
    • US11259434
    • 2005-10-25
    • David SteinQing GeJianzhu ChenPatrick Iversen
    • David SteinQing GeJianzhu ChenPatrick Iversen
    • A61K48/00C07F9/6533C07H21/02
    • C12N15/1131C12N2310/3145C12N2310/3233C12N2310/3513
    • The invention provides antisense antiviral compounds and methods of their use and production in inhibition of growth of viruses of the Orthomyxoviridae family and in the treatment of a viral infection. The compounds are particularly useful in the treatment of influenza virus infection in a mammal. The antisense antiviral compounds are substantially uncharged morpholino oligonucleotides having 1) a nuclease resistant backbone, 2) 12-40 nucleotide bases, and 3) a targeting sequence of at least 12 bases in length that hybridizes to a target region selected from the following: a) the 5′ or 3′ terminal 25 bases of the negative sense viral RNA segment of Influenzavirus A, Influenzavirus B and Influenzavirus C; b) the terminal 25 bases of the 3′ terminus of the positive sense cRNA and; and c) the 50 bases surrounding the AUG start codon of an influenza viral mRNA.
    • 本发明提供反义抗病毒化合物及其在抑制正粘病毒科的病毒生长和用于病毒感染治疗中的用途和生产方法。 该化合物特别可用于治疗哺乳动物的流感病毒感染。 反义抗病毒化合物是基本上不带电荷的吗啉代寡核苷酸,其具有1)核酸酶抗性主链,2)12-40个核苷酸碱基,和3)长度为至少12个碱基的靶向序列与选自以下的靶区域杂交: )流感病毒A,流感病毒B和流感病毒C的负义病毒RNA片段的5'或3'末端25个碱基; b)正义cRNA的3'末端的末端25个碱基; 和c)围绕流感病毒mRNA的AUG起始密码子的50个碱基。
    • 9. 发明申请
    • Antisense antiviral compounds and methods for treating a filovirus infection
    • 反义抗病毒化合物和治疗病毒感染的方法
    • US20060205693A1
    • 2006-09-14
    • US11264444
    • 2005-10-31
    • David SteinPatrick IversenSina Bavari
    • David SteinPatrick IversenSina Bavari
    • A61K48/00
    • C12N15/1131C12N2310/11C12N2310/31C12N2310/32C12N2310/3513
    • The invention provides antisense antiviral compounds and methods of their use and production in inhibition of growth of viruses of the Filoviridae family, and in the treatment of a viral infection. The compounds and methods relate to the treatment of viral infections in mammals including primates by Ebola and Marburg viruses. The antisense antiviral compounds are substantially uncharged morpholino oligonucleotides having: a) a nuclease resistant backbone, b) 15-40 nucleotide bases, and c) a targeting sequence of at least 15 bases in length that hybridizes to a target region selected from the following: i) the AUG start site region of VP35, as exemplified by antisense compounds SEQ ID NO:21-26, ii) the AUG start site region of VP24, as exemplified by antisense compound SEQ ID NO:34, iii) the region 85 to 65 base pairs upstream of the AUG start site of VP24, as exemplified by SEQ ID NO:39, iv) the AUG start site region of polymerase L, as exemplified by antisense compound SEQ ID NO: 17, and v) combinations of (i), (ii), (iii), and/or (iv).
    • 本发明提供了反义抗病毒化合物及其在抑制丝状病毒科病毒生长和用于病毒感染治疗中的用途和生产方法。 该化合物和方法涉及哺乳动物中的病毒感染的治疗,包括埃博拉和马尔堡病毒的灵长类动物。 反义抗病毒化合物是基本上不带电荷的吗啉代寡核苷酸,其具有:a)核酸酶抗性主链,b)15-40个核苷酸碱基,和c)长度为至少15个碱基的靶向序列与选自以下的靶区域杂交: i)VP35的AUG起始位点区域,如反义化合物SEQ ID NO:21-26所示,ii)VP24的AUG起始位点区域,如反义化合物SEQ ID NO:34所示,iii)区域85至 VP24的AUG起始位点上游65个碱基对,如SEQ ID NO:39所示,iv)聚合酶L的AUG起始位点区域,如反义化合物SEQ ID NO:17所示,v)(i ),(ii),(iii)和/或(iv)。